Prospective randomised comparison of granulocyte colony-stimulating factor (G-CSF) (filgrastim) secondary prophylaxis versus conservative management of chemotherapy-induced neutropenia to maintain dose intensity in chemotherapy for breast cancer http://www.cancerresearchuk.org/cancer-help/trials/a-trial-using-gcsf-to-try-to-reduce-the-risk-of-infection-in-people-having-chemotherapy-for-breast-cancer

• Pays Aucun
• Organes Aucun
• Spécialités Aucune

A randomised two-arm, prospective, multi-centre, open-label phase III trial comparing the activity and safety of a weekly versus a three-weekly paclitaxel treatment schedule in patients with advanced or metastatic breast cancer http://cancerhelp.cancerresearchuk.org/trials/a-trial-looking-at-weekly-versus-3-weekly-paclitaxel-for-breast-cancer-that-has-spread

• Pays United Kingdom
• Organes Aucun
• Spécialités Aucune